Sabme Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.51 M
- Revenue Growth 27.90%
- Profit Growth 60.81%
- Ebitda 97.52%
- Net Worth 88.56%
- Total Assets -4.09%
About Sabme Pharmaceuticals
Sabme Pharmaceuticals Private Limited (SPPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 December 2018 (Six years and two months 5 days old ). Its registered office is in Singhbhum, Jharkhand, India.
The Company is engaged in the Engineering Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.51 M.
Rishab Agarwal and Resham Kaur serve as directors at the Company.
Company Details
-
Location
Singhbhum, Jharkhand, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999JH2018PTC012244
-
Company No.
012244
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
06 Dec 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jharkhand
Industry
Who are the key members and board of directors at Sabme Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rishab Agarwal
|
Director | 06-Dec-2018 | Current |
|
Resham Kaur
|
Director | 06-Dec-2018 | Current |
Financial Performance of Sabme Pharmaceuticals.
Sabme Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 27.9% increase. The company also saw a substantial improvement in profitability, with a 60.81% increase in profit. The company's net worth Soared by an impressive increase of 88.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sabme Pharmaceuticals?
Unlock access to Sabme Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Sammarsa Pharmaceutical Private LimitedRishab Agarwal is a mutual person
-
Dhisanalok Private Limited
Rishab Agarwal is a mutual person
-
Seetri Pharmaceutical Private Limited
Resham Kaur is a mutual person
Charges (Loans)
₹3.51 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jun 2022 | Hdfc Bank Limited | ₹2.11 M | Open |
| 03 Mar 2021 | Hdfc Bank Limited | ₹1.40 M | Open |
How Many Employees Work at Sabme Pharmaceuticals?
Sabme Pharmaceuticals has a workforce of 0 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sabme Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sabme Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
